Literature DB >> 15099983

Massive edema of the ovary: a report of two cases due to lymphatic permeation by metastatic carcinoma from the uterine cervix.

Maja Krasević1, Herman Haller, Stanko Rupcić, Senija Behrem.   

Abstract

BACKGROUND: Massive ovarian edema (MOE) due to permeation of the ovarian lymphatics by metastatic carcinoma is rare, with a few cases reported to date. CASES: We present two cases of MOE in patients with advanced carcinoma of the uterine cervix. Bilateral and unilateral MOEs in the first and second case, respectively, due to lymphatic permeation of the ovaries by metastatic squamous cell carcinoma and adenocarcinoma were found. Details of clinical history, operative procedure, pathological findings, therapy, and outcome are summarized.
CONCLUSION: MOE is the unusual manifestation of the metastatic disease of the ovaries from the carcinomas of the uterine cervix in these cases.

Entities:  

Mesh:

Year:  2004        PMID: 15099983     DOI: 10.1016/j.ygyno.2004.02.015

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Massive ovarian edema with torsion: unusual hemorrhage and the recovery of contrast enhancement.

Authors:  Tsuneo Yamashiro; Morihiko Inamine; Hisashi Kamiya; Ayano Kinjo; Sadayuki Murayama; Yoichi Aoki
Journal:  Emerg Radiol       Date:  2007-06-26

Review 2.  Massive ovarian oedema: a misleading clinical entity.

Authors:  Nikolaos Machairiotis; Aikaterini Stylianaki; Paraskevi Kouroutou; Polixeni Sarli; Nikolaos Konstantinos Alexiou; Elias Efthymiou; Athanasios Maras; Nikolaos Georgios Alexiou; Spyridon Evaggelos Nikolaou; Nikolaos Courcoutsakis; Eleni Papakonstantinou; Paul Zarogoulidis; Nikolaos Barbetakis; Dimitrios Paliouras; Apostolos Gogakos; Christodoulos Machairiotis
Journal:  Diagn Pathol       Date:  2016-02-03       Impact factor: 2.644

3.  A clinical update on massive ovarian oedema - a pseudotumour?

Authors:  Rs Praveen; Vr Pallavi; K Rajashekar; A Usha; K Umadevi; Ud Bafna
Journal:  Ecancermedicalscience       Date:  2013-05-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.